Thrombophilia and cancer in the pathogenesis of arterial thrombosis

Journal of Clinical and Basic Cardiology

Volumn 3, Issue 2, 2000, Pages 89-90

  Brenner, Benjamin ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Arterial thrombosis; Cancer; Homocysteine; Thrombophilia

Indexed keywords

AMINO ACID DEFICIENCY; ANTICOAGULATION; ARTERY THROMBOSIS; CANCER DIAGNOSIS; ENZYME DEFECT; GENETIC DISORDER; HUMAN; HYPERHOMOCYSTEINEMIA; NUTRITIONAL DEFICIENCY; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA;

EID: 0033802054     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Inherited thrombophilia: Part 1
2. Inherited thrombophilia: Part 2
3. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism
4. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
5. Coexistence of familial antiphospholipid syndrome and factor V Leiden - Impact on thrombotic diathesis
6. Disorders of transsulfuration
7. Inherited disorders of folate transport and metabolism
8. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
9. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency
10. Association between plasma homocysteine concentratons and extracranial carotid-artery stenosis
11. Plasma homocysteine as a risk factor for early familial coronary artery disease
12. Plasma homocysteine and cardiovascular disease
13. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults
14. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians
15. Thermolabile methylene tetrahydrofolate reductase: An inherited risk factor for coronary artery disease
16. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia
17. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
18. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
19. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥ 40 μmol/liter)
20. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
21. The natural history of homocysteinuria due to cystathionine β-synthase deficients
22. Coexistence of hereditary homocysteinuria and factor V Leiden - Effect on thrombosis
23. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
24. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
25. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
26. Oxidation of low density lipoproteins by thiol compounds leads to its recognition by the acetyl LDL receptor
27. Homocysteine and other sulphydryl compounds enhance the binding of lipoprotein (a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulphydryl compound metabolism
28. Malignancy and haemostasis
29. Cardiac valvular vegetations in cancer patients - A prospective echocardiographic study of 200 patients
30. Cardiac involvement in patients with myeloproliferative disorders
31. Cancer cell procoagulants and their pharmacological modulation
32. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia on all-trans-retinoic acid